breaking above double top and ready to run.
with 15.00 to 16.00 in earnings for 2015 and selling at 10 times forward earnings with the growth potential of many many new drugs it shouldn't be selling at multiples of stogy big cap drug companies like merck, PFE act.
stock should at least be caring a market multiple at the very least which would put it up in the 200+
oppenheimer has big institutional clients at these conferences that will buy into the huge upcoming potential
of OMER. 2014 will be a big year for OMER!
been too quiet here for a company with so much going on
no panic, losses cover by insurance
no loss of customers, have plenty of product to cover that too............so why panic?
oh your short and trying to cause a dump! lol Get a life!
business loss insurance in place to cover both asset loss and business loss. They also had stockpiled product so they will still have product to cover sales. Just a small bump